
PrNMI
CAS No. 1541244-33-0
PrNMI( —— )
Catalog No. M12180 CAS No. 1541244-33-0
PrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 745 | Get Quote |
![]() ![]() |
10MG | 1017 | Get Quote |
![]() ![]() |
25MG | 1431 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePrNMI
-
NoteResearch use only, not for human use.
-
Brief DescriptionPrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist.
-
DescriptionPrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist, significantly alleviates spontaneous pain behaviors in the animals.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1541244-33-0
-
Formula Weight409.573
-
Molecular FormulaC29H31NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name4-{2-[-(1E)-1[(4-propylnaphthalen-1-yl)methylidene]-1H-inden-3-yl]ethyl}morpholine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Pain. 2018 May 16. doi: 10.1097/j.pain.0000000000001278.
molnova catalog



related products
-
Hemopressin (human, ...
Bioactive endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE. Ki values are 27.76, 3.43 and 1.87 μM respectively. Potent hypotensive in vivo. Also acts as a selective CB1 receptor inverse agonist. Displays antinociceptive activity in vivo.
-
GAT-211
GAT-211 (GAT211) is a selective cannabinoid 1 receptor (CB1R) positive allosteric modulator with pKb of 7.26, Arrestin2 EC50 of 775 nM.
-
PSNCBAM-1
PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.